Insufficient scRNA-seq data for expression of ALKAL1 at single-cell level.
Insufficient scRNA-seq data for expression of ALKAL1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 97.89 | 651 / 653 | 85% | 8.95 | 512 / 605 |
bladder | 81% | 50.29 | 17 / 21 | 68% | 4.64 | 344 / 504 |
stomach | 47% | 12.11 | 168 / 359 | 80% | 5.82 | 229 / 286 |
intestine | 44% | 24.54 | 423 / 966 | 71% | 4.72 | 373 / 527 |
pancreas | 41% | 5.84 | 136 / 328 | 71% | 4.02 | 127 / 178 |
lung | 51% | 12.91 | 294 / 578 | 55% | 3.43 | 640 / 1155 |
esophagus | 56% | 46.33 | 809 / 1445 | 32% | 1.33 | 58 / 183 |
prostate | 55% | 25.48 | 135 / 245 | 29% | 0.94 | 148 / 502 |
liver | 34% | 4.88 | 76 / 226 | 13% | 1.01 | 52 / 406 |
blood vessel | 28% | 8.88 | 373 / 1335 | 0% | 0 | 0 / 0 |
kidney | 19% | 2.48 | 17 / 89 | 8% | 0.31 | 69 / 901 |
ovary | 0% | 0 | 0 / 180 | 21% | 1.01 | 91 / 430 |
uterus | 5% | 1.19 | 9 / 170 | 13% | 0.65 | 58 / 459 |
brain | 14% | 1.51 | 358 / 2642 | 2% | 0.04 | 12 / 705 |
skin | 10% | 1.29 | 186 / 1809 | 1% | 0.01 | 4 / 472 |
breast | 6% | 0.69 | 27 / 459 | 2% | 0.29 | 25 / 1118 |
tonsil | 0% | 0 | 0 / 0 | 7% | 0.40 | 3 / 45 |
adrenal gland | 1% | 0.38 | 3 / 258 | 1% | 0.02 | 3 / 230 |
eye | 0% | 0 | 0 / 0 | 1% | 0.01 | 1 / 80 |
adipose | 1% | 0.18 | 14 / 1204 | 0% | 0 | 0 / 0 |
muscle | 0% | 0.01 | 1 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0070378 | Biological process | positive regulation of ERK5 cascade |
GO_0007169 | Biological process | cell surface receptor protein tyrosine kinase signaling pathway |
GO_0070374 | Biological process | positive regulation of ERK1 and ERK2 cascade |
GO_0010976 | Biological process | positive regulation of neuron projection development |
GO_0005615 | Cellular component | extracellular space |
GO_0005886 | Cellular component | plasma membrane |
GO_0030298 | Molecular function | receptor signaling protein tyrosine kinase activator activity |
GO_0005515 | Molecular function | protein binding |
GO_0030971 | Molecular function | receptor tyrosine kinase binding |
GO_0030297 | Molecular function | transmembrane receptor protein tyrosine kinase activator activity |
GO_0005125 | Molecular function | cytokine activity |
Gene name | ALKAL1 |
Protein name | ALK and LTK ligand 1 (Augmentor beta) (AUG-beta) |
Synonyms | UNQ9433/PRO34745 FAM150A |
Description | FUNCTION: Cytokine that acts as a physiological ligand for receptor tyrosine kinase LTK, leading to its activation . Monomeric ALKAL1 binds to LTK, leading to LTK homodimerization and activation . In contrast to ALKAL2, does not act as a potent physiological ligand for ALK . . |
Accessions | Q6UXT8 ENST00000358543.9 [Q6UXT8-1] ENST00000523939.1 [Q6UXT8-2] |